Chemo Pharma Laboratories

Chemo Pharma Laboratories

120.10
-6.25
(-4.95%)
Market Cap
18.06 Cr
EPS
-9.66
PE Ratio
59.17
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
154.00
52 Week Low
59.58
PB Ratio
1.44
Debt to Equity
0.00
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,639.70
#1 3,93,418.96
34.30
#1 54,729.00
9.71
#1 10,980
-19.84
47.35
6,175.00
1,63,926.85
69.37
9,712.00
18.67
2,191
26.74
35.29
1,590.80
1,28,490.16
23.86
28,409.50
7.12
5,291
9.88
66.07
3,661.50
1,23,921.80
61.13
11,539.40
6.99
1,911
19.91
59.05
2,604.30
1,07,486.95
56.78
12,744.20
#1 20.90
2,007
-18.14
60.15
1,275.00
1,06,407.81
#1 18.75
33,741.20
16.73
5,725
1.26
57.30
993.60
99,979.41
21.29
23,511.00
18.55
4,615
2.60
56.17
1,970.10
89,973.57
24.22
22,909.50
13.74
3,306
#1 51.64
53.40
32,745.00
69,580.84
47.71
6,684.70
9.64
1,414
11.55
44.46
5,470.00
65,402.06
28.51
13,458.30
3.70
2,216
21.39
70.65
Forecast
Actual
Growth Rate
Revenue Growth
-
Net Income Growth
-
Cash Flow Change
-101.57 %
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-

Yearly Financial Results

Annual Financials
2016
TTM
Revenue
-1
0
Expenses
0
0
EBITDA
-1
0
Operating Profit %
0 %
0 %
Depreciation
0
0
Interest
0
0
Profit Before Tax
-1
0
Tax
0
0
Net Profit
-1
0
EPS in ₹
-9.66
0.00

Balance Sheet

Balance Sheet
2016
Total Assets
4
Fixed Assets
0
Current Assets
2
Capital Work in Progress
0
Investments
0
Other Assets
4
Total Liabilities
4
Current Liabilities
0
Non Current Liabilities
0
Total Equity
4
Reserve & Surplus
2
Share Capital
2

Cash Flow

Cash Flow
2016
Net Cash Flow
0
Investing Activities
2
Operating Activities
-2
Financing Activities
0

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.28 %
0.17 %
0.17 %
0.17 %
0.17 %
0.17 %
0.37 %
0.37 %
0.37 %
0.17 %
0.37 %
0.17 %
0.37 %
0.37 %
0.37 %
0.37 %
0.37 %
0.37 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
65.76 %
65.77 %
65.51 %
65.70 %
65.74 %
65.72 %
65.57 %
65.38 %
65.40 %
65.56 %
65.55 %
65.51 %
65.61 %
65.63 %
65.60 %
65.50 %
65.29 %
65.77 %
Others
6.07 %
6.17 %
6.44 %
6.25 %
6.21 %
6.22 %
6.18 %
6.37 %
6.35 %
6.39 %
6.19 %
6.44 %
6.14 %
6.12 %
6.15 %
6.25 %
6.46 %
5.98 %
No of Share Holders
5,949
6,082
6,129
6,213
6,225
6,226
6,226
6,274
6,289
6,268
6,275
6,254
6,262
6,254
6,382
6,576
6,510
6,422

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
24 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
24 Sept 2025 141.55 126.35
23 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
23 Sept 2024 73.50 69.41
28 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Oct 2024 72.10 67.00
27 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
27 Jan 2025 101.90 89.50
29 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 May 2025 124.45 147.65
12 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Aug 2025 126.80 141.55

Announcements

Board Meeting Intimation for Intimation Of Board Meeting To Be Held On August 22 20257 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication7 days ago
Intimation Of Book Closure And Record Date For The Annual General Meeting To Be Held For The Financial Year 2024-20259 days ago
Submission Of Un-Audited Financial Results For The Quarter Ended June 30 20259 days ago
Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday August 12 2025.9 days ago
Intimation Of Receipt Of Request For Reclassification From Promoter Group Shareholder To Public Shareholder Under Regulation 31A Of The SEBI (LODR) Regulations 201510 days ago
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 05, 2025
Board Meeting Outcome for Outcome Of Board Meeting. INTIMATION OF APPOINTMENT OF STATUTORY AUDITORJul 31, 2025
Board Meeting Intimation for Board Meeting IntimationJul 28, 2025
Announcement under Regulation 30 (LODR)-Resignation of Statutory AuditorsJul 24, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jul 21, 2025
Disclosure Under Regulation 7(2) Read With Regulation 6(2) - Disclosure Of SEBI (Prohibition Of Insider Trading) Regulations 2015 - Atibha Agriseeds Private LimitedJul 21, 2025
Disclosure Under Regulation 7(2) Read With Regulation 6(2) - Disclosure Of SEBI (Prohibition Of Insider Trading) Regulations 2015 - Shanta SomaniJul 21, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jul 21, 2025
Disclosure Under Regulation 7(2) Read With Regulation 6(2) - Disclosure Of SEBI (Prohibition Of Insider Trading) Regulations 2015 - Atibha Agriseeds Private LimitedJul 15, 2025
Closure of Trading WindowJul 15, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jul 15, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jul 15, 2025
Disclosure Under Regulation 7(2) Read With Regulation 6(2) - Disclosure Of SEBI (Prohibition Of Insider Trading) Regulations 2015 - Citric India LimitedJul 14, 2025
Intimation Of Appointment Of Secretarial AuditorJul 09, 2025
Declaration Of Non-Applicability Of Regulation 23(9) Of SEBI (LODR) Regulation 2015Jul 08, 2025
Declaration Of Non-Applicability Of Regulation 23(9) Of SEBI (LODR) Regulation 2015Jul 07, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 04, 2025
Updates on Open OfferJun 19, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 30, 2025
Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31 2025May 29, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On May 29 2025May 29, 2025
Updates on Open OfferMay 28, 2025
Intimation With Respect To Opening Of New Corporate Office Of The CompanyMay 27, 2025
Updates on Open OfferMay 21, 2025
Updates on Open OfferMay 20, 2025
Board Meeting Intimation for Board Meeting To Be Held On Thursday May 29 2025May 14, 2025
Letter of OfferMay 13, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 08, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Friday May 02 2025May 02, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementApr 23, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementApr 23, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementApr 16, 2025
Board Meeting Outcome for OUTCOME OF THE BOARD MEETING HELD ON WEDNESDAY APRIL 16 2025Apr 16, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 16, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 15, 2025
Declaration Of Non-Applicability Of Regulation 23(9) Of SEBI (LODR) Regulation 2015Apr 15, 2025
Board Meeting Intimation for Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligation And Disclosure Requirement) Regulations 2015 Board Meeting To Be Held On Wednesday April 16 2025Apr 08, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 02, 2025
Closure of Trading WindowMar 31, 2025
Draft Letter of OfferFeb 28, 2025
Detailed Public StatementFeb 24, 2025
Intimation Of Signing Of Share Purchase Agreement (SPA) Between The Promoter & Promoter Group And AcquirerFeb 18, 2025
Submission Of Public Announcement To The Public Shareholders Of M/S Chemo Pharma Laboratories LimitedFeb 18, 2025
Public Announcement - Open OfferFeb 18, 2025

Technical Indicators

RSI(14)
Neutral
45.28
ATR(14)
Less Volatile
9.94
STOCH(9,6)
Neutral
27.77
STOCH RSI(14)
Oversold
12.71
MACD(12,26)
Bearish
-1.16
ADX(14)
Weak Trend
20.71
UO(9)
Bearish
46.00
ROC(12)
Downtrend And Accelerating
-0.35
WillR(14)
Oversold
-85.02